Publications
Blood Test May Detect Pancreatic Cancer
Conquest - Spring 2010
A blood test for four small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, says Subrata Sen, Ph.D., associate professor in MD Anderson’s Department of Molecular Pathology and senior author on the study that provided this discovery.
Subrata Sen, Ph.D. (left), and Jin Wang, Ph.D.
Sen and colleagues are working with the Early Detection Research Network of the National Cancer Institute. Their goal is to develop expanded studies with larger sample sizes that will test the molecular markers associated with different grades and stages of pancreatic cancer.
Currently, there is no accurate, non-invasive way to detect the disease, the fourth-leading cause of cancer-related deaths in the United States. Fewer than 5% of patients survive five years.
Reported in the September 2009 edition of the journal Cancer Prevention Research.
Conquest - Spring 2010
Features
- Pathology: Investigating the Nature of Cancer
- What's in a Name? — New Logo Features Strike Through Cancer
- Found in Translation: SPORE Grants Turn Into Hope for Patients
- Transforming Cancer Care:
MD Anderson Launches Public Phase of Capital Campaign - Supportive Care Center Helps Manage Symptoms Throughout Cancer Journey
- Enlightened Choices: Individualized Options for Prostate Cancer Patients
- Moving Forward: Kevin Olson
Frontline
- Study Shifts Assessment of Certain Breast Cancer Patients
- An Advance for Multiple Myeloma Patients
- Team of Two Oncoproteins Crucial Step in Metastasis
- Blood Test May Detect Pancreatic Cancer
- Combined Therapies Show Promise in Small Cell Lung Cancer
- What Predicts Smoking Risk for Mexican-American Youth?
- Racial Disparities in Radiation Therapy for Early-Stage Breast Cancer